Gilead Sciences, Inc. (<a rel="nofollow" class="qLink" href="#" OnClick="singleQuoteDialog('GILD'); return false;">GILD</a>) 13D/13G Filings for Arcus Biosciences, Inc. (<a rel="nofollow" class="qLink" href="#" OnClick="singleQuoteDialog('RCUS'); return false;">RCUS</a>)

Gilead Sciences, Inc. 13D and 13G filings for Arcus Biosciences, Inc.:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
Shares have been adjusted for stock splits.

Reported DateTime	Transaction Date	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	View
2025-03-05 5:00 pm Unchanged	2025-02-18	13D	Arcus Biosciences, Inc. RCUS	GILEAD SCIENCES INC GILD	39,691,649 35.000%	0 (Unchanged)	Filing
2025-02-20 7:43 pm Purchase	2025-02-18	13D	Arcus Biosciences, Inc. RCUS	GILEAD SCIENCES INC GILD	39,691,649 35.000%	8,158,868 (+25.87%)	Filing
2024-01-31 4:58 pm Purchase	2024-01-29	13D	Arcus Biosciences, Inc. RCUS	GILEAD SCIENCES INC GILD	31,532,781 35.000%	5,945,828 (+23.24%)	Filing
2023-07-06 09:38 am Purchase	2023-06-28	13D	Arcus Biosciences, Inc. RCUS	GILEAD SCIENCES INC GILD	25,586,953 35.000%	2,863,797 (+12.60%)	Filing
2021-02-02 4:51 pm Sale	2021-01-31	13D	Arcus Biosciences, Inc. RCUS	GILEAD SCIENCES INC GILD	22,723,156 35.000%	-6,775,268 (-22.97%)	Filing
2020-07-17 2:01 pm Purchase	2020-07-08	13D	Arcus Biosciences, Inc. RCUS	GILEAD SCIENCES INC GILD	29,498,424 35.000%	29,498,424 (New Position)	Filing